Private company
Defunct healthcare company
Ionian Technologies Inc. was a United States Biotechnology Company focused on molecular diagnostics development for the detection of infectious diseases and biothreat agents. It was established in 2000 in Upland, California as the first spin-off company to commercialize technology developed at the Keck Graduate Institute. Since its inception Ionian has expanded its isothermal amplification technology.2 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
See how the biggest companies compare on our leaderboards
Ionian Technologies Inc. was a United States Biotechnology Company focused on molecular diagnostics development for the detection of infectious diseases and biothreat agents. It was established in 2000 in Upland, California as the first spin-off company to commercialize technology developed at the Keck Graduate Institute. Since its inception Ionian has expanded its isothermal amplification technology. Ionian was acquired in July 2010 by Alere Inc, which was later acquired by Abbott Labs in 2017.2
Ionian Technologies is part of a group headed by Abbott Laboratories. 542 entities, 71 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0). Each entity in the chart links to its source.
Ionian traces its origins to Dr. David J. Galas who was previously co-founder, Chancellor, Chief Scientific Officer and Norris Professor of Applied Life Science at the Keck Graduate Institute (KGI) of Applied Life Sciences. During his development of KGI he spun off Ionian Technologies from work done in his lab, based upon a 2003 PNAS paper.
In 2001, Ionian was incorporated in Delaware.
From Wikipedia’s article on Ionian Technologies, shared under CC BY-SA 4.0.3
Ionian's proprietary isothermal technology, termed the Nicking Enzyme Amplification Reaction Assay, is claimed to be capable of amplifying extremely low amounts of starting material to easily detectable levels in just a few minutes. The proprietary technology is based on the very rapid detection of small DNA or RNA fragments generated directly from the target nucleic acid. The amplification products can be detected by a variety of standard methods, including LC-MS, real-time fluorescence, lateral flow and capillary electrophoresis detection. Ionian's assay technology is therefore ideally suited for portable and handheld detectors and sensors.
From Wikipedia’s article on Ionian Technologies, shared under CC BY-SA 4.0.3
The numbers on this page point here. Each one links to the record it came from.
